TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 122 filers reported holding TCR2 THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 2.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,203,203 | +54.1% | 1,468,802 | +2.6% | 0.00% | – |
| Q4 2022 | $1,429,628 | -44.6% | 1,431,346 | -0.1% | 0.00% | – |
| Q3 2022 | $2,581,000 | -33.3% | 1,433,425 | +7.4% | 0.00% | – |
| Q2 2022 | $3,869,000 | +36.0% | 1,334,359 | +29.4% | 0.00% | – |
| Q1 2022 | $2,845,000 | -54.8% | 1,030,897 | -23.7% | 0.00% | – |
| Q4 2021 | $6,295,000 | -49.1% | 1,350,777 | -7.1% | 0.00% | – |
| Q3 2021 | $12,373,000 | -45.7% | 1,454,072 | +4.7% | 0.00% | -100.0% |
| Q2 2021 | $22,800,000 | -24.7% | 1,389,360 | +1.3% | 0.00% | 0.0% |
| Q1 2021 | $30,282,000 | -13.8% | 1,371,503 | +20.7% | 0.00% | 0.0% |
| Q4 2020 | $35,146,000 | +58.8% | 1,136,322 | +4.3% | 0.00% | 0.0% |
| Q3 2020 | $22,131,000 | +181.1% | 1,089,091 | +112.5% | 0.00% | – |
| Q2 2020 | $7,872,000 | +108.8% | 512,470 | +5.2% | 0.00% | – |
| Q1 2020 | $3,770,000 | -44.8% | 487,003 | +1.8% | 0.00% | – |
| Q4 2019 | $6,830,000 | -2.3% | 478,255 | +2.8% | 0.00% | – |
| Q3 2019 | $6,994,000 | +553.6% | 465,369 | +522.3% | 0.00% | – |
| Q2 2019 | $1,070,000 | – | 74,779 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $4,046,814 | 1.69% |
| MPM BioImpact LLC | 3,370,982 | $3,367,611 | 0.87% |
| TANG CAPITAL MANAGEMENT LLC | 2,738,947 | $2,735,660 | 0.40% |
| Newtyn Management, LLC | 1,075,000 | $1,073,710 | 0.22% |
| HARBOR CAPITAL ADVISORS, INC. | 68,230 | $68,148 | 0.07% |
| Artal Group S.A. | 750,000 | $749 | 0.04% |
| Oasis Management Co Ltd. | 200,000 | $199,760 | 0.04% |
| Redmile Group, LLC | 731,379 | $730,501 | 0.03% |
| X-Square Capital, LLC | 31,919 | $32 | 0.02% |
| CORNERCAP INVESTMENT COUNSEL INC | 68,035 | $67,953 | 0.01% |